Print Friendly, PDF & Email

Author Archives: kkc

Research Study: An Open Label Study to Evaluate CORT125134 in Patients with Cushing Syndrome


The purpose of this study is to evaluate a new investigational medication for patients who have Cushing syndrome due to the body’s production of too much cortisol.

This study is an open label study. That means both the health providers and the participants in the study are aware of the drug or treatment being given.

This is a Phase 2 trial. A Phase 2 trial means that the study drug has been taken before by healthy volunteers under supervision. In this current trial, the study drug is being used for the first time in patients with Cushing syndrome.

The multicenter study will be conducted in the United States and in Europe.

Eligibility criteria:


  1. Diagnosis of Cushing syndrome caused by the body’s production of too much cortisol (not caused by steroid medication)
  2. Requires medical treatment for Cushing syndrome
  3. Meets at least one of the following criteria:
    1. Has type 2 diabetes or impaired glucose tolerance (has a high blood sugar level)
    2. Has high blood pressure

Exclusion criteria:

Not Allowed

  1. Diagnosis of Cushing syndrome caused by steroid medication
  2. Poorly controlled blood pressure
  3. Severe kidney disease

These and other eligibility criteria are best reviewed with a doctor who is participating in the study. You can also get more detailed eligibility information about the study by visiting (NCT02804750) or the Pre-screener.

Study Details:

  • Patients will be treated with the study drug for 12 weeks and will be evaluated every two weeks at the clinical research site
  • Patients will be assigned to one of two groups, each with a two-step increase in medication doses; blood samples will be taken at every dose level to understand how the study drug is broken down and released from the body
  • A placebo is not being used for this trial
  • The sponsor of this trial is Corcept Therapeutics
  • The results of this trial will be published
  • All study related medications, analysis, hospital visits, and procedures are at no cost

Study Locations:

The study is currently taking place in the United States, United Kingdom, Netherlands, Italy, and Hungary.

Additional information on the study is available from:

Study sponsor: Corcept Therapeutics

For more information, please contact:

Andreas G. Moraitis, MD

tel: +1 (347) 754-1993 or [email protected]

Coping Strategies have a Strong Impact on Quality of Life, Depression, and Embitterment in Patients with Cushing’s Disease

A chronic illness such as Cushing’s is likely to change your life in many ways. You may have had symptoms from excessive cortisol levels for quite a long time before Cushing’s was suspected and finally confirmed. Diagnosis is oftentimes followed by surgery and may also involve being on medication or receiving radiotherapy. Your illness isContinue Reading

Permanent Adrenal Insufficiency: Effects on Longevity and Quality of Life

Most patients with Cushing’s disease are successfully treated by transsphenoidal pituitary surgery and most cases of adrenal based Cushing’s syndrome require the removal of only one adrenal gland. In cases such as these, adrenal insufficiency (lack of sufficient hormone production from the adrenal glands) is almost always temporary and patients usually recuperate within one year.Continue Reading

CSRF Represented at NORD Breakthrough Summit

In October 2016, Leslie Edwin attended the National Organization for Rare Disorder’s (NORD) Rare Diseases & Orphan Products Breakthrough Summit in Washington, D.C. She was joined by D.C. Support Group members Eugenia and Amy, plus Amy’s service dog, Sam. At least a dozen people now know about Cushing’s thanks to Sam – he was quiteContinue Reading

Summary of Survey on How Cushing’s Affect Your Relationships

In September of 2016, the CSRF asked for your input on if and how Cushing’s impacted your relationships. Thank you to all who replied! The information we received was shared with a researcher in the area of quality of life and Cushing’s. Thanks to your responses, the degree of relationship problems associated with Cushing’s stimulatedContinue Reading


Contact Us